{
  "ticker": "CDNA",
  "company_name": "CareDx, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT04177095",
      "title": "Immune Monitoring to Facilitate Belatacept Monotherapy",
      "status": "COMPLETED",
      "phase": "PHASE4",
      "condition": "Kidney Transplant Rejection, Immunosuppression",
      "start_date": "2020-02-11",
      "completion_date": "2023-06-01",
      "enrollment": 0,
      "sponsor": "Massachusetts General Hospital"
    },
    {
      "nct_id": "NCT07230886",
      "title": "Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft Dysfunction",
      "status": "NOT_YET_RECRUITING",
      "phase": "NA",
      "condition": "Primary Graft Dysfunction",
      "start_date": "2025-11",
      "completion_date": "2028-12",
      "enrollment": 0,
      "sponsor": "University Health Network, Toronto"
    }
  ],
  "summary": {
    "total_trials": 2,
    "by_phase": {
      "PHASE4": 1,
      "NA": 1
    },
    "by_status": {
      "COMPLETED": 1,
      "NOT_YET_RECRUITING": 1
    },
    "active_trials": 0,
    "completed_trials": 1,
    "conditions": [
      "Kidney Transplant Rejection, Immunosuppression",
      "Primary Graft Dysfunction"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:43:34.107019",
    "search_query": "CareDx, Inc.",
    "url": "https://clinicaltrials.gov/search?term=CareDx,+Inc."
  }
}